Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hexavalent Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06947499
What this trial is testing

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 1,186
Large-scale testing (Phase 3)Looking for participantsNCT06608199
What this trial is testing

Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Who this might be right for
Pneumococcal VaccinesPneumococcal Infections
Beijing Minhai Biotechnology Co., Ltd 500
Very early researchUnknownNCT05805618
What this trial is testing

Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects

Who this might be right for
Gastroenteritis
Syneos Health 60
Testing effectiveness (Phase 2)Looking for participantsNCT06967272
What this trial is testing

PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

Who this might be right for
Rotavirus Gastroenteritis
Sinovac Life Sciences Co., Ltd. 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196
What this trial is testing

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336